You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Prostate cancer discovery opens door to more tailored treatments
- 2. Prostate cancer, race and the need for tests | Letters
- 3. Human medicines European public assessment report (EPAR): Zadenvi, denosumab, Status: Opinion
- 4. Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
- 5. Revealing propionate metabolism-related genes in glioblastoma and investigating their underlying mechanisms
- 6. Discovery of FOXR2 activation in various brain tumours refines diagnosis to improve care
- 7. IV medication could be taken orally for range of cancer, Alzheimer's treatments
- 8. Solid subtype of adenoid cystic carcinoma of the breast with multiple distant metastases: a case report and literature review
- 9. Development and validation of a preoperative magnetic resonance imaging-based and machine learning model for the noninvasive differentiation of intracranial glioblastoma, primary central nervous system lymphoma and brain metastases: a retrospective analysis
- 10. Three-dimensional gene hubs may promote brain cancer
Last updated at 19:09 GMT
Hot News Makers
Health/Pharma Companies
-
195706.24
-
189996.28
-
184693.60
-
39574.79
-
21086.00
-
18905.30
-
13047.41
-
12594.32
-
11589.91
-
11354.33
Drugs, Treatments, Trials
-
38519.76
-
19581.04
-
15757.14
-
13253.56
-
8923.11
-
8319.39
-
5174.26
-
4729.75
-
4084.99
-
3838.76
Last updated at 18:10 GMT
